Investigative site

Atlanta, Georgia 30342

0 studies enrolling now · 9 studies all time

What they study most

Alport Syndrome, Covid19, Focal Segmental Glomerulosclerosis, Heavy Menstrual Bleeding, Lumbosacral Radiculopathy, Menorrhagia, Multiple Myeloma, Overactive Bladder (OAB), Pancreatic Cancer

Studies at this site

• Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients — Completed
• Study to Evaluate R3R01 in Patients With Alport Syndrome and Patients With Focal Segmental Glomerulosclerosis — Completed
• Intramuscular and Intravenous VIR-7831 (Sotrovimab) for Mild/Moderate COVID-19. — Stopped early
• VIR-7831 for the Early Treatment of COVID-19 in Outpatients — Completed
• Efficacy of Perifosine Alone and in Combination With Dexamethasone for Patients With Multiple Myeloma — Completed
• Efficacy and Safety of XP12B in Women With Menorrhagia — Completed
• Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy — Completed
• Efficacy and Safety Study of XP12B in Women With Menorrhagia — Completed
• Patient's Perception of Treatment Outcome With Darifenacin by Patients With Overactive Bladder — Completed